GATTO, LIDIA
 Distribuzione geografica
Continente #
NA - Nord America 1.972
EU - Europa 1.308
AS - Asia 257
AF - Africa 113
SA - Sud America 7
OC - Oceania 5
Totale 3.662
Nazione #
US - Stati Uniti d'America 1.967
IT - Italia 312
GB - Regno Unito 264
SE - Svezia 214
CN - Cina 140
DE - Germania 129
CH - Svizzera 95
IE - Irlanda 81
IN - India 54
TG - Togo 54
FR - Francia 48
RU - Federazione Russa 43
VN - Vietnam 31
CI - Costa d'Avorio 27
FI - Finlandia 22
BG - Bulgaria 21
EE - Estonia 21
ZA - Sudafrica 21
JO - Giordania 13
UA - Ucraina 11
BE - Belgio 10
NG - Nigeria 9
AT - Austria 7
PL - Polonia 6
SK - Slovacchia (Repubblica Slovacca) 6
AU - Australia 5
CA - Canada 5
HR - Croazia 4
NL - Olanda 4
CL - Cile 3
IR - Iran 3
RO - Romania 3
BR - Brasile 2
JP - Giappone 2
LB - Libano 2
NO - Norvegia 2
SG - Singapore 2
TR - Turchia 2
TW - Taiwan 2
AR - Argentina 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
EC - Ecuador 1
EG - Egitto 1
ES - Italia 1
GR - Grecia 1
HK - Hong Kong 1
KR - Corea 1
KZ - Kazakistan 1
MA - Marocco 1
MY - Malesia 1
PT - Portogallo 1
SA - Arabia Saudita 1
UZ - Uzbekistan 1
Totale 3.662
Città #
Chandler 262
Southend 250
Fairfield 244
Ashburn 153
Houston 99
Woodbridge 98
Bern 92
Wilmington 91
Princeton 88
Seattle 88
Bologna 85
Ann Arbor 84
Dublin 81
Cambridge 68
Redmond 60
Lomé 54
New York 34
Berlin 28
Abidjan 27
Westminster 24
Helsinki 22
Beijing 21
Sofia 21
Nanjing 20
San Diego 16
Turin 16
Padova 15
Amman 13
Kuban 13
Ravenna 13
Falls Church 12
Jinan 12
Shenyang 12
Naples 10
Torino 10
Abeokuta 9
Brussels 9
Changsha 8
Zhengzhou 8
Bremen 7
Florence 7
Hebei 7
Milan 7
Norwalk 7
Olalla 7
Saint Petersburg 7
Boydton 6
Hefei 6
London 6
Nanchang 6
Rome 6
San Francisco 6
Dearborn 5
Forlì 5
Jiaxing 5
Monmouth Junction 5
Redwood City 5
Vienna 5
Warsaw 5
Žilina 5
Bentivoglio 4
Cesena 4
Chicago 4
Des Moines 4
Hangzhou 4
Kunming 4
Montescudo 4
Toronto 4
Andover 3
Ardabil 3
Boardman 3
Canberra 3
Dong Ket 3
Fremont 3
Guangzhou 3
Lanzhou 3
Medford 3
Paris 3
Pescara 3
Phoenix 3
Sacramento 3
Tianjin 3
Baotou 2
Boston 2
Bühl 2
Casalgrande 2
Costa Mesa 2
Fiume Veneto 2
Haikou 2
Hyderabad 2
Isera 2
Kemerovo 2
Leawood 2
Los Angeles 2
Luzzara 2
Napoli 2
Oslo 2
Parma 2
Piacenza 2
Silverton 2
Totale 2.505
Nome #
Follow-up del cancro del pancreas esocrino 191
18F-FDG-PET/CT imaging in cardiac tumors: illustrative clinical cases and review of the literature. 172
Molecular modelling evaluation of exon 18 His845_Asn848delinsPro pDGFRα mutation in a metastatic GIST patient responding to imatinib 150
An exploratory association of polymorphisms in angiogenesis-related genes with susceptibility, clinical response and toxicity in gastrointestinal stromal tumors receiving sunitinib after imatinib failure 143
Good survival outcome of metastatic SDH-deficient gastrointestinal stromal tumors harboring SDHA mutations 137
Genome-wide analysis identifies MEN1 and MAX mutations and a neuroendocrine-like molecular heterogeneity in Quadruple WT GIST 136
A Single-Centre Experience on the Management of Adenosarcoma: A Successful Report of an Integrated Medical and Surgical Approach 131
Integrated Molecular Characterization of Gastrointestinal Stromal Tumors (GIST) Harboring the Rare D842V Mutation in PDGFRA Gene. 127
Whole Exome Sequencing Uncovers Germline Variants of Cancer-Related Genes in Sporadic Pheochromocytoma 121
Personalization of regorafenib treatment in metastatic gastrointestinal stromal tumours in real-life clinical practice 120
An exploratory study by DMET array identifies a germline signature associated with imatinib response in gastrointestinal stromal tumor 115
Integrating miRNA and gene expression profiling analysis revealed regulatory networks in gastrointestinal stromal tumors 114
Successful treatment with personalized dosage of imatinib in elderly patients with gastrointestinal stromal tumors 113
Immune microenvironment profiling of gastrointestinal stromal tumors (GIST) shows gene expression patterns associated to immune checkpoint inhibitors response 108
Surgical second-look in high risk gastrointestinal stromal tumor of small intestine: A case report. 100
Efficacy of weekly docetaxel in locally advanced cardiac angiosarcoma 98
null 98
Successful selective arterial embolizations for bone metastases in renal cell carcinoma integrated with systemic therapies: A case report 95
Radiotherapy in the management of gist: state of the art and new potential scenarios 94
Immune-checkpoint inhibitors in previously treated patients with advanced or metastatic urothelial carcinoma: A systematic review and meta-analysis 91
Case Report: The Complete Remission of a Mixed Germ Cell Tumor With Somatic Type Malignancy of Sarcoma Type With a GCT-Oriented Therapy: Clinical Findings and Genomic Profiling 89
SDHA and SDHB mutations in KIT/PDGFRA WT gastrointestinal stromal tumors 88
Molecular characterization of metastatic exon 11 mutant gastrointestinal stromal tumors (GIST) beyond KIT/PDGFRα genotype evaluated by next generation sequencing (NGS) 84
The human microbiota and prostate cancer: Friend or foe? 80
Paratesticular Mesenchymal Malignancies: A Single-Center Case Series, Clinical Management, and Review of Literature 74
Clinical and Molecular Features of Patients with Gliomas Harboring IDH1 Non-canonical Mutations: A Systematic Review and Meta-Analysis. 72
Optical coherence tomography assessment of macrophages accumulation in non-ST-segment elevation acute coronary syndromes. 60
The clinical and prognostic role of ALK in glioblastoma 56
Association between socioeconomic status and survival in glioblastoma: An Italian single-centre prospective observational study 55
Engineered CAR-T and novel CAR-based therapies to fight the immune evasion of glioblastoma: gutta cavat lapidem 53
Clinical efficacy of immune checkpoint inhibitors in patients with brain metastases 51
Distinct MRI pattern of "pseudoresponse" in recurrent glioblastoma multiforme treated with regorafenib: Case report and literature review 50
Expertise is crucial to prolong survival in average risk medulloblastoma: long-term results of a retrospective study 47
Discovering the molecular landscape of meningioma: The struggle to find new therapeutic targets 46
Is Molecular Tailored-Therapy Changing the Paradigm for CNS Metastases in Breast Cancer? 45
Idh1 non-canonical mutations and survival in patients with glioma 40
IDH1105GGT single nucleotide polymorphism improves progression free survival in patients with IDH mutated grade II and III gliomas 40
Glioblastoma: Emerging treatments and novel trial designs 40
IDH Inhibitors and Beyond: The Cornerstone of Targeted Glioma Treatment 40
Hypothyroidism in patients with hepatocellular carcinoma receiving cabozantinib: An unassessed issue 40
Radiomics, mirnomics, and radiomirRNomics in glioblastoma: defining tumor biology from shadow to light 31
Adult Medulloblastoma: Updates on Current Management and Future Perspectives 30
Meningioma: Not always a benign tumor. A review of advances in the treatment of meningiomas 30
Machine learning in neuro-oncology: toward novel development fields 27
Polymorphisms in DNA repair genes in gastrointestinal stromal tumours: susceptibility and correlation with tumour characteristics and clinical outcome 26
Encephalic Leukocytoclastic Vasculitis during Treatment with Sunitinib for Renal Cell Carcinoma: A Case Report 22
Liquid Biopsy in Glioblastoma Management: From Current Research to Future Perspectives. 17
Adjuvant therapy in renal cell carcinoma-is pharmacogenomics assessment another element to select our patients? 15
Combination immunotherapy in metastatic renal cell carcinoma. Are we leaving something back? 13
Key role of obesity in genitourinary tumors with emphasis on urothelial and prostate cancers 8
Recent Advances in Liquid Biopsy in Patients With Castration Resistant Prostate Cancer 7
The Biological and Clinical Role of the Telomerase Reverse Transcriptase Gene in Glioblastoma: A Potential Therapeutic Target? 7
Resistance to systemic agents in renal cell carcinoma predict and overcome genomic strategies adopted by tumor 6
Optimizing renal function and outcome of patients with cT2 renal cell carcinoma 4
Hypothyroidism in patients with hepatocellular carcinoma receiving cabozantinib: an unassessed issue 2
New Hormonal Agents in Patients With Nonmetastatic Castration-Resistant Prostate Cancer: Meta-Analysis of Efficacy and Safety Outcomes 1
Immune-checkpoint inhibitors in previously treated patients with advanced or metastatic urothelial carcinoma: A systematic review and meta-analysis 1
Totale 3.851
Categoria #
all - tutte 11.070
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.070


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201956 0 0 0 0 0 0 0 0 0 0 24 32
2019/2020841 91 20 4 41 94 76 128 116 106 78 53 34
2020/2021377 88 31 22 7 7 16 11 39 73 14 21 48
2021/2022855 57 31 19 44 67 37 15 97 46 75 245 122
2022/20231.193 104 153 52 131 77 112 39 73 216 43 59 134
2023/2024348 44 78 26 34 19 76 12 30 7 22 0 0
Totale 3.851